The Role of SIRT1 in Cancer

作者: Melissa J. Wilking , Nihal Ahmad

DOI: 10.1016/J.AJPATH.2014.10.002

关键词: Cancer researchCancerProstate cancerNeurodegenerationSuppressorBiologyImmunologyMitophagyHistoneSirtuin 1Context (language use)Pathology and Forensic Medicine

摘要: In recent years, the importance of histone deacetylases in cancer development has become increasingly apparent. Many nonhistone protein targets have been identified as tumor suppressors or promoters, and aberrant expression regulation therefore shown to either oncogenic protective consequences.1 SIRT1, a member NAD+-dependent class III known Sirtuins, play role not only cancer, but also number other physiological processes health conditions, including metabolic disease, inflammation, neurodegeneration, cardiovascular disease.2, 3 The SIRT1 remains controversial many studies suggested promoter function whereas suppressor this sirtuin.4 In issue American Journal Pathology, Di Sante et al5 weigh on controversy with compelling data supporting status prostate cancer. They used Sirt1−/− mouse model fibroblasts demonstrate against induction intraepithelial neoplasia, increased cellular proliferation, accompanied mitophagy. addition, they that inhibits reactive oxygen species production induces superoxide dismutase 2 activity, TP63 increases loss SIRT1. Here, we discuss implications these findings context current research regarding promoter.

参考文章(16)
Masaya Tanno, Jun Sakamoto, Tetsuji Miura, Kazuaki Shimamoto, Yoshiyuki Horio, Nucleocytoplasmic Shuttling of the NAD+-dependent Histone Deacetylase SIRT1 Journal of Biological Chemistry. ,vol. 282, pp. 6823- 6832 ,(2007) , 10.1074/JBC.M609554200
Melissa J. Wilking, Chandra Singh, Minakshi Nihal, Weixiong Zhong, Nihal Ahmad, SIRT1 deacetylase is overexpressed in human melanoma and its small molecule inhibition imparts anti-proliferative response via p53 activation Archives of Biochemistry and Biophysics. ,vol. 563, pp. 94- 100 ,(2014) , 10.1016/J.ABB.2014.04.001
WenYong Chen, Hongfeng Yuan, Leila Su, The emerging and diverse roles of sirtuins in cancer: a clinical perspective. OncoTargets and Therapy. ,vol. 6, pp. 1399- 1416 ,(2013) , 10.2147/OTT.S37750
D Herranz, A Maraver, M Canamero, G Gomez-Lopez, L Inglada-Perez, M Robledo, E Castelblanco, X Matias-Guiu, M Serrano, None, SIRT1 promotes thyroid carcinogenesis driven by PTEN deficiency. Oncogene. ,vol. 32, pp. 4052- 4056 ,(2013) , 10.1038/ONC.2012.407
Gabriele Di Sante, Timothy G. Pestell, Mathew C. Casimiro, Sara Bisetto, Michael J. Powell, Michael P. Lisanti, Carlos Cordon-Cardo, Mireia Castillo-Martin, Dennis M. Bonal, Valentina Debattisti, Ke Chen, Liping Wang, Xiaohong He, Michael W. McBurney, Richard G. Pestell, Loss of Sirt1 Promotes Prostatic Intraepithelial Neoplasia, Reduces Mitophagy, and Delays Park2 Translocation to Mitochondria The American Journal of Pathology. ,vol. 185, pp. 266- 279 ,(2015) , 10.1016/J.AJPATH.2014.09.014
Rui-Hong Wang, Kundan Sengupta, Cuiling Li, Hyun-Seok Kim, Liu Cao, Cuiying Xiao, Sangsoo Kim, Xiaoling Xu, Yin Zheng, Beverly Chilton, Rong Jia, Zhi-Ming Zheng, Ettore Appella, Xin Wei Wang, Thomas Ried, Chu-Xia Deng, Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell. ,vol. 14, pp. 312- 323 ,(2008) , 10.1016/J.CCR.2008.09.001
Walter Stünkel, Robert M. Campbell, Sirtuin 1 (SIRT1) The Misunderstood HDAC Journal of Biomolecular Screening. ,vol. 16, pp. 1153- 1169 ,(2011) , 10.1177/1087057111422103
Carles Cantó, Johan Auwerx, Caloric restriction, SIRT1 and longevity. Trends in Endocrinology and Metabolism. ,vol. 20, pp. 325- 331 ,(2009) , 10.1016/J.TEM.2009.03.008
Qi Long, Jianpeng Xu, Adeboye O. Osunkoya, Soma Sannigrahi, Brent A. Johnson, Wei Zhou, Theresa Gillespie, Jong Y. Park, Robert K. Nam, Linda Sugar, Aleksandra Stanimirovic, Arun K. Seth, John A. Petros, Carlos S. Moreno, Global transcriptome analysis of formalin-fixed prostate cancer specimens identifies biomarkers of disease recurrence. Cancer Research. ,vol. 74, pp. 3228- 3237 ,(2014) , 10.1158/0008-5472.CAN-13-2699
Chu-Xia Deng, SIRT1, is it a tumor promoter or tumor suppressor? International Journal of Biological Sciences. ,vol. 5, pp. 147- 152 ,(2009) , 10.7150/IJBS.5.147